Navigation Links
Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
Date:10/6/2009

p 50 - drug delivery deals 2003 to 2008

Figure 7: Inactive bigpharma in drug delivery dealmaking 2003-2008

Figure 8: Drug delivery partnering by deal type since 2003

Figure 9: Drug delivery option deals since 2003

Figure 10: Drug delivery partnering by disease type from 2003

Figure 11: Drug delivery M&A since 2000

Figure 12: Top drug delivery deals by value since 2000

Figure 13: Top drug delivery deals signed by bigpharma value since 2000

Figure 14: Top drug delivery M&A deals by value since 2000

Figure 15: Online partnering resources

Figure 16: Forthcoming partnering events

Figure 17: Deal type definitions

Figure 18: Drug delivery partnering agreement between Solvay and Depomed, November 2008

To order this report:

Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech

http://www.reportlinker.com/p0151441/Reportlinker-Adds-Drug-Delivery-Partnering-Agreements-in-Pharma-and-Biotech.html

More market research reports here!

    CONTACT:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
5. Study Shows Intradigms RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
8. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
9. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
10. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
11. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015  VirtualScopics, Inc. (NASDAQ: ... imaging solutions, announced today, they are collaborating with ... new philanthropic, epidemiology study partnering with the Ministry ...  VirtualScopics has teamed up with a cardiac sonographer ... image results will be used to identify children ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ( ... "Investigation Report on China Olmesartan Market, 2010-2019" report ... medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd ... olmesartan medoxomil was approved by FDA to enter the ... best- selling drug in the world after it succeeded ...
(Date:9/3/2015)... , Sep. 03, 2015 ... ) has announced the addition of the ... 2010-2019" report to their offering. ... totally different chemical structure from steroids which ... can also provide analgestic and antipyretic effects ...
Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4China Olmesartan Investigation Market Report 2010-2019 2China Flurbiprofen Market Investigation Report 2010-2019 2
... of evaluable heavily-pretreated patients in the high dose ... tolerated overall.DALLAS, March 5 ACCESS PHARMACEUTICALS, ... safety and efficacy results from its Phase 2 ... heavily pretreated ovarian cancer patients. In this monotherapy ...
... March 4 A new study by researchers at ... essential B vitamins, including B6, B12, and folic acid, ... of the leading causes of vision loss among older ... key omega-3 fatty acids and phytosterols, are also contained ...
Cached Medicine Technology:Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 2Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 3Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 4Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss 2
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... included Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private ... that "only a tiny fraction of the nation's companies have demonstrated such remarkably ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... 2015: DiabetesSisters is pleased to announce the additional of Carol Wysham, MD, to ... current board members Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We ... which can impact the delicate life balance between work and leisure to the ... Jeffrey R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly ...
(Date:9/3/2015)... ... , ... Mum n Me is pleased to announce the launch of its ... gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n Me ... by keeping the cover securely in place. The new car seat cover is made ...
Breaking Medicine News(10 mins):Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:Mum n Me Announces New Baby Car Seat Cover 2
... Rare Town Hall Meeting With U.S. Senator Arlen Specter ... CostsPHILADELPHIA, Feb. 18 AARP Pennsylvania, Business Roundtable, National ... Union held a town hall meeting today on the ... in Philadelphia at the National Constitution Center. While in ...
... New research finds misdiagnosis risk goes up as age goes ... boy complaining of numbness at a Detroit emergency room was ... A 24-year-old woman with sharp pain in her left eye ... by ER doctors that she had a migraine. , And ...
... letter to be published in this week,s Journal ... S. Stanley Young, Assistant Director of Bioinformatics at the ... of British Columbia, highlight the statistical limitations of a ... diabetes and abnormal blood level liver,enzyme levels. The earlier ...
... Monthly menstrual cycles produce many ... cramps, headaches and bloating. With more intense, painful ... vomiting also is a symptom. This monthly recurrence ... study in the November/December 2008 issue of General ...
... (2/18/2009) -- Autism Speaks today announced initial results ... Autism Clinical Trials Network (ACTN), the Study of ... fluoxetine was not effective for reducing repetitive behaviors ... compared to placebo (non-medicinal sugar pill). The study ...
... CRH Medical announced today that for the year ended December ... for Colorectal Health compared to 13,461 for the same period ... Program, the Company sold 6,840 units of its CRH O,Regan ... in 2007. The Company trained more than 100 physicians in ...
Cached Medicine News:Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 2Health News:Divided We Fail Pushes to Keep Health Care Reform as a Top Priority for Congress and the New Administration 3Health News:ER Less Likely to Diagnose Stroke in Younger Folks 2Health News:ER Less Likely to Diagnose Stroke in Younger Folks 3Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 2Health News:Women Only: Cramps, Bloating and Now, Tooth Erosion? 3Health News:Autism Speaks reports Neuropharm's SOFIA results 2Health News:Autism Speaks reports Neuropharm's SOFIA results 3Health News:CRH experiences significant increase in business activity 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: